Bayforest Capital Ltd Invests $30,000 in Schrodinger, Inc. $SDGR

Bayforest Capital Ltd bought a new stake in Schrodinger, Inc. (NASDAQ:SDGR) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,469 shares of the company’s stock, valued at approximately $30,000.

Several other institutional investors also recently bought and sold shares of SDGR. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Schrodinger by 169.0% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,357,532 shares of the company’s stock valued at $86,018,000 after acquiring an additional 2,737,728 shares in the last quarter. American Century Companies Inc. acquired a new stake in Schrodinger in the first quarter valued at approximately $19,787,000. Stephens Investment Management Group LLC boosted its stake in Schrodinger by 22.5% in the first quarter. Stephens Investment Management Group LLC now owns 1,969,941 shares of the company’s stock valued at $38,887,000 after acquiring an additional 362,285 shares in the last quarter. Jones Financial Companies Lllp boosted its stake in Schrodinger by 34,925.9% in the first quarter. Jones Financial Companies Lllp now owns 216,110 shares of the company’s stock valued at $4,266,000 after acquiring an additional 215,493 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Schrodinger in the first quarter valued at approximately $4,027,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Schrodinger Trading Down 4.9%

NASDAQ:SDGR opened at $19.31 on Friday. The firm has a fifty day simple moving average of $19.60 and a 200-day simple moving average of $21.34. Schrodinger, Inc. has a 12 month low of $16.60 and a 12 month high of $28.47. The company has a market capitalization of $1.42 billion, a P/E ratio of -7.79 and a beta of 1.74.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.83) by $0.24. Schrodinger had a negative net margin of 76.22% and a negative return on equity of 45.70%. The firm had revenue of $54.76 million during the quarter, compared to analysts’ expectations of $52.03 million. During the same quarter last year, the company posted ($0.66) earnings per share. The firm’s revenue was up 15.7% compared to the same quarter last year. Equities analysts forecast that Schrodinger, Inc. will post -2.37 EPS for the current year.

Insider Activity

In related news, insider Margaret Dugan sold 1,395 shares of the firm’s stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $21.07, for a total transaction of $29,392.65. Following the completion of the transaction, the insider owned 24,574 shares of the company’s stock, valued at $517,774.18. This trade represents a 5.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 21.00% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on SDGR shares. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a research note on Tuesday, October 14th. Morgan Stanley lowered their price objective on shares of Schrodinger from $28.00 to $19.00 and set an “equal weight” rating for the company in a research note on Monday, August 18th. KeyCorp lowered their price objective on shares of Schrodinger from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. The Goldman Sachs Group began coverage on shares of Schrodinger in a research note on Monday, September 29th. They set a “neutral” rating and a $19.00 price objective for the company. Finally, Barclays began coverage on shares of Schrodinger in a research note on Thursday, August 14th. They set an “overweight” rating and a $25.00 price objective for the company. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $26.29.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.